PROMUS Element Plus US Post-Approval Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2681 participants.
Also called NCT01589978
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,681 participants
- Sponsor
- Registry
-
NCT01589978
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01589978. Allocation not applicable; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2014-08 (actual). Results posted on 2016-05-03.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PROMUS Element Plus US Post-Approval Study
- Condition
- Coronary Artery Disease
- Intervention (Device)
- PROMUS Element Plus Coronary Stent System
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- P2Y12 antagonist
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct01589978- Content hash
e06cc35bd8d2d3b5fc86786217da0b8646ae56c413de64901f9e6da407997667